Magenta Therapeutics, Inc.MGTANASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-8561.44%
↓ 656% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
-1132.80%
Historical baseline
PeriodValueYoY Change
TTM-8561.44%-424.0%
2024-1633.74%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-
20170.00%-
20160.00%-